BioSig Technologies to participate in Needham Virtual Crypto 1x1 Conference.
ByAinvest
Thursday, Aug 28, 2025 8:34 am ET1min read
BSGM--
The conference provides an opportunity for the companies to showcase their advancements in bringing the gold market onto the blockchain. Streamex, a wholly owned subsidiary of BioSig, specializes in building infrastructure to tokenize gold, aiming to create a new on-chain gold market. The company's technology is designed to enable a gold-denominated treasury and tokenization, which could revolutionize the way gold is traded and held.
Henry McPhie and Mitch Williams will engage with institutional investors to discuss the potential of this technology and its implications for the gold market. The meeting format will allow for in-depth discussions and the exchange of ideas, which could foster new partnerships and investment opportunities.
BioSig Technologies, Inc., on the other hand, is a medical device technology company with an advanced digital signal processing technology platform. The PURE EP™ Platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. This diverse portfolio indicates BioSig's commitment to innovation across different sectors.
The participation in the conference underscores BioSig's and Streamex's commitment to innovation and their vision for the future of the gold market. The companies hope to use this platform to educate investors and industry stakeholders about their technology and its potential applications.
References:
[1] https://www.stocktitan.net/news/BSGM/streamex-bsgm-to-participate-in-the-5th-annual-needham-virtual-i6v6g0p281c8.html
BioSig Technologies, Inc. and its subsidiary Streamex, a gold tokenization infrastructure company, will participate in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. BioSig and Streamex CEO, Henry McPhie, and CIO, Mitch Williams, will host one-on-one meetings with institutional investors. The company is building infrastructure to bring the gold market on-chain through a gold-denominated treasury and tokenization technology.
BioSig Technologies, Inc. and its subsidiary Streamex, a gold tokenization infrastructure company, have announced their participation in the 5th annual Needham Virtual Crypto 1x1 Conference on September 4th, 2025. The event will see the attendance of BioSig and Streamex CEO Henry McPhie and CIO Mitch Williams, who will host one-on-one meetings with institutional investors.The conference provides an opportunity for the companies to showcase their advancements in bringing the gold market onto the blockchain. Streamex, a wholly owned subsidiary of BioSig, specializes in building infrastructure to tokenize gold, aiming to create a new on-chain gold market. The company's technology is designed to enable a gold-denominated treasury and tokenization, which could revolutionize the way gold is traded and held.
Henry McPhie and Mitch Williams will engage with institutional investors to discuss the potential of this technology and its implications for the gold market. The meeting format will allow for in-depth discussions and the exchange of ideas, which could foster new partnerships and investment opportunities.
BioSig Technologies, Inc., on the other hand, is a medical device technology company with an advanced digital signal processing technology platform. The PURE EP™ Platform delivers insights to electrophysiologists for ablation treatments of cardiovascular arrhythmias. This diverse portfolio indicates BioSig's commitment to innovation across different sectors.
The participation in the conference underscores BioSig's and Streamex's commitment to innovation and their vision for the future of the gold market. The companies hope to use this platform to educate investors and industry stakeholders about their technology and its potential applications.
References:
[1] https://www.stocktitan.net/news/BSGM/streamex-bsgm-to-participate-in-the-5th-annual-needham-virtual-i6v6g0p281c8.html
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue
Comments
No comments yet